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Abstract
Expression of the cyclin kinase inhibitor, p21, is regulated both transcriptionally and posttranscriptionally by the
ubiquitin-proteasome degradation pathway. Recently, we reported that DNA damage is required for efficient p21 expression
by demonstrating that enhanced p21 mRNA expression induced by DNA damage results in increased p21 protein, but
enhanced p21 mRNA without DNA damage does not. In addition, we demonstrated that DNA damage suppressed the
ubiquitination of p21. In this study, we analyze the link between p21 stabilization and DNA damage. Enhanced p21 protein
expression in ML-1 cells resulting from 15 Gy Q-irradiation was diminished by Wortmannin or LY294002 pretreatment of
cells. However, the levels of p21 mRNA were not affected by inhibitor pretreatment. Wortmannin or LY294002 pretreatment
reduces p53 expression after Q-irradiation to a lesser degree than that of p21. In addition, we examined the involvement of
DNA-PK, whose activity is inhibited by Wortmannin or LY294002, in p21 stabilization using the SCID fibroblast cell line
and a DNA-PK targeting ML-1 cell line. Accumulation of p21 protein by Q-irradiation was similar to that of DNA-PK intact
cells and was reduced by Wortmannin or LY294002 pretreatment. Involvement of another DNA damage detecting enzyme,
the ATM gene product, whose activity is also inhibited by Wortmannin or LY294002, was evaluated. ATM deficient cells
induced p21 after Q-irradiation, Q-irradiation-induced p21 protein was diminished by pretreatment of cells with Wortmannin
or LY294002. We conclude that the p21 stabilization mechanism functions after Q-irradiation, was sensitive to Wortmannin
or LY294002, and required neither DNA-PK nor ATM gene product for activity. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The progression of the cell cycle is precisely con-
trolled by cyclin-dependent kinases (CDKs). The se-
quential activation of CDKs is accomplished by as-
sociation of each CDK with a speci¢c cyclin subunit
[1,2]. In the mammalian cell cycle, G1 progression is
driven by cyclin D associated with either CDK4 or
CDK6, while G1/S transition requires both cyclin
E/CDK2 and cyclin A/CDK2 [1]. As the cell cycle
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progresses, each cyclin is degraded and the phase
speci¢c CDK activity is diminished [3,4]. However,
to ensure the prevention of an unscheduled entry
into S phase, the activity of the cyclin/CDK complex
is suppressed by association with CDK inhibitors [5].
For control at the G1-S checkpoint, there are two
groups of CDK inhibitors, the p21 family and the
p16INK4 family. Ample evidence suggests that the
expression of cyclin kinase inhibitors is regulated
both at the transcriptional level and at the protein
level [5,6].
When dividing cells are exposed to genetic stress,
the cell cycle must be arrested immediately to ensure
the integrity of the DNA and/or cell cycle control.
Cyclin kinase inhibitors should be constitutively ex-
pressed in cells to prepare their prompt response
against genetic stress during G1. If the cell cycle pro-
gresses from G1 to S on schedule without DNA dam-
age, those inhibitors are to be degraded through the
ubiquitin proteasome pathway as are cyclins [7].
Consequently, it is conceivable that DNA damage
brings about accumulation of cyclin kinase inhibitors
by inhibiting their degradation.
The direct association of DNA damage and cell
cycle regulation has been described through the
phosphorylation of p53 by a phosphatidylinositol
(PI) 3-kinase family member, either DNA-dependent
protein kinase (DNA-PK) or the ataxia telangiectasia
mutated (ATM) gene product. DNA-PK is known to
phosphorylate a number of proteins in vitro, p53 and
other proteins with roles in replication or regulation
of the cell cycle (c-Myc, c-Fos, c-Jun, topoisomerases
I and II) [8]. ATM gene product is thought to be
involved in sensing DNA damage due to the variety
of abnormalities in A-T cells [9]. p53 is a cell cycle
regulatory protein whose degradation is inhibited by
DNA damage-induced phosphorylation [10]. Re-
cently, evidence has been presented that suggests
the phosphorylation of p53, by DNA-PK or ATM
at serine 15 in the amino terminal transactivation
domain, leads to stabilization of p53 by inhibiting
its recognition by Mdm2 E3 ubiquitin ligase [11^
13]. Other reports, however, have demonstrated
that DNA-PK in not required for the p53-dependent
response to DNA damage [14,15]. These con£icting
reports of the cellular response(s) to DNA damage
are ambiguous and demonstrate the need for further
study.
The expression of cyclin kinase inhibitor p21 has
been shown to be regulated by the ubiquitin-protea-
some degradation pathway [16^19]. We recently re-
ported that the treatment of ML-1 cells with deferox-
amine, an iron chelator that functions as a inhibitor
of deoxyribonucleotide reductase, causes an accumu-
lation of p53 and the induction of p21 mRNA but
not p21 protein [20,21]. When ML-1 cells were
treated with etoposide, a DNA damaging agent,
p53 accumulation with an increase of p21 mRNA
followed by induction of p21 protein was observed
[19]. In an attempt to analyze the ubiquitination of
p21 after DNA damage, we analyzed ubiquitinated
p21 in cells treated with various agents. Ubiquiti-
nated p21 is detectable after deferoxamine and pro-
teasome inhibitor treatment, but not in cells treated
with etoposide [19,21]. Others have reported that UV
and ionizing radiation have no e¡ect on either the
stability or the in vivo ubiquitination of p21 in U2OS
cells, a human osteosarcoma cell line that expresses
wild-type p53 [17]. Further, no direct evidence exists
that DNA damage stabilizes CDK inhibitors. How-
ever, in our previous experiments comparing DNA
damaging agents with a non-DNA damaging stimu-
lant that induces p53 and p21 mRNA, we demon-
strated that DNA damage increases the expression of
p21 protein through posttranscriptional regulation
[19]. The mechanism(s) by which DNA damage re-
sults in the stabilization of p21 is unknown. How-
ever, given that p21 is degraded via the ubiquitin-
proteasome degradation pathway, one possibility is
that DNA damaging agents somehow signal a re-
pression of the ubiquitin-mediated degradation of
p21. Involvement of DNA damage in regulation of
the ubiquitin-proteasome pathway was demonstrated
as the contribution of DNA damage-sensing protein
kinases, DNA-PK or ATM, in the regulation of p53-
ubiquitination by phosphorylation. According to
these observations, in the present study, we examined
the involvement of DNA-PK and ATM in p21 stabi-
lization.
2. Materials and methods
2.1. Cells and chemicals
ML-1, a human myelocytic leukemia cell line
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(wild-type functional p53), and NIH3T3 mouse ¢-
broblast were supplied by the Health Science Re-
search Resource Bank (HSRRB). The SV40 trans-
formed severe combined immunode¢ciency (SCID)
mouse ¢broblast cell line, SC3VA4, is kindly sup-
plied by Dr. M. Abe (National Institute of Radio-
logical Science) [22]. Epstein-Barr virus (EBV) trans-
formed lymphoblastoid cell lines from patients with
ataxia telangiectasia (A-T), AT1ABR and AT3ABR,
were kindly provided by Dr. Martin Lavin (Queens-
land Inst. Med. Res., Brisbane, Australia). The
AT1ABR cell produces a near full length ATM
gene product with a deletion of three amino acids
(2546^2548) upstream from the PI 3 kinase domain
[23,24]. The AT3ABR cell has a mutation, A8266T,
and the 350 kDa ATM protein is not detected [24].
ML-1, AT1ABR and AT3ABR cells were cultured in
RPMI 1640 supplemented with 10% fetal calf serum
at 37‡C in a humidi¢ed 5% CO2 incubator. Cells
were cultured at a concentration between 2U105
and 1U106/ml. Exponentially growing ML-1 cells
were prepared by seeding at a concentration of
2U105/ml 24 h prior to treatment. NIH3T3 cells
were cultured in Dulbecco’s modi¢ed Eagle’s essen-
tial medium (DMEM) containing 10% calf serum at
37‡C in a humidi¢ed 5% CO2 incubator, and
SC3VA4 cells were cultured in DMEM containing
10% fetal calf serum under the same conditions. Cells
were seeded at 1U106 cells in 10 cm diameter dishes
and passaged every third day. Exponentially growing
NIH3T3 cells or SC3VA4 cells were prepared by
seeding at a concentration of 3U105 cells in 25 cm2
culture £ask 24 h prior to treatment.
Either Wortmannin (Sigma) or LY294002 (Sigma)
were dissolved in dimethyl sulfoxide (DMSO) at a
concentration of 1U1032 M. Q-Irradiation (IR) was
performed at room temperature with a Gammacell
3000 Elan (Nordion International, Canada) with a
137Cs source emitting at a ¢xed dose rate of 3.1 Gy
min31.
2.2. Protein extraction and Western blot analysis
Cells (2U107) were harvested, washed with phos-
phate bu¡ered saline (PBS) and then lysed in 1 ml of
lysis bu¡er (1% Nonidet P-40, 1U1032 M sodium
phosphate pH 7.2, 1.5U1031 M NaCl, 1U1033 M
EDTA, 5U1032 M sodium £uoride, 1U1032 M so-
dium orthovanadate, 2 Wg/ml aprotinin, 2 Wg/ml leu-
peptin, 5 Wg/ml phenylmethylsulfonyl £uoride and
60 Wg/ml N-ethylmaleimide). After incubation on
ice for 30 min, the lysate was clari¢ed by ultracen-
trifugation at 105 000Ug for 1 h at 4‡C. The protein
concentration of the cell lysate was determined with
the Bradford method [25]. For Western blot analysis,
1% sodium dodecyl sulfate (SDS) and 2.5% L-mer-
captoethanol were added to the cell lysate (30 Wg)
and heated for 5 min at 100‡C. Denatured samples
were applied on 10^20% or 4^15% SDS-polyacryl-
amide gel electrophoresis using a running bu¡er of
2.5U1032 M Tris-HCl pH 8.3, 1.92U1031 M gly-
cine, 0.1% SDS. The gels were electroblotted (5 mA/
cm2, 2 h) onto a polyvinylidene di£uoride (PVDF)
membrane (Bio-Rad, CA) in a transfer bu¡er of
2.5U1032 M Tris-HCl pH 8.3, 1.92U1031 M glycine
and 20% methanol. The membranes were incubated
with 10% nonfat dry milk in PBS, then incubated
with either anti-p21 rabbit polyclonal antibody
(1:200, H164; 1:200, C-19, Santa Cruz Biotechnol-
ogy, CA), anti-p53 monoclonal antibody (1:500,
DO-1, Santa Cruz) or anti DNA-PKcs rabbit poly-
clonal antibody (1:200, C-19, Santa Cruz) diluted
in 1U1032 M Tris-HCl pH 8.3, 5U1031 M NaCl
(TBS) for 1 h at room temperature. The blot was
washed in TBS with 0.05% Tween 20 (TTBS) to re-
move unbound antibody and incubated with a bio-
tinylated anti-rabbit IgG or biotinylated anti-mouse
IgG in TBS for 1 h at room temperature. The mem-
brane was again washed in TTBS and incubated in
streptavidin-biotinylated alkaline phosphatase com-
plex. After washing thoroughly, Nitroblue tetrazo-
lium chloride/5-bromo-4-chloro-3-indolyl-phosphate
(NBT/BCIP) substrate was used to visualize the
bands. The same blot was probed with an anti-L-
tubulin monoclonal antibody (5H1, Pharmingen,
CA) to control the amount of protein loaded onto
the gel. The band density was quanti¢ed by Image
Master (Pharmacia, Sweden). The fold increase in
protein expression in relation to the expression in
untreated control cells was indicated.
2.3. Northern blot analysis
RNA extraction and Northern blot hybridization
were performed as described previously [20]. Cells
were lysed in of 5 M guanidine isothiocyanate then
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extracted with phenol-chloroform. RNA (20 Wg) was
treated with 50% formamide and separated on a
1.0% agarose gel in 6.6U1031 M formaldehyde,
2U1032 M 3-morpholinopropanesulfonic acid
(MOPS) pH 7.0 and transferred to a positive charged
nylon membrane, Hybond N (Amersham, UK).
p21 cDNA (provided by Dr. Noda, Meiji Cell Tech-
nology Center, Japan) and L-actin DNA were dig-
oxygenin-labeled by the random primer method. Hy-
bridization was performed in 50% formamide,
5USSC (1USSC: 1.5U1031 M NaCl, 1.5U1032 M
sodium citrate), sodium phosphate pH 7.0, 7% SDS,
at 50‡C for 16 h. After washing with 2USSC, 0.1%
SDS at room temperature then with 0.1USSC, 0.1%
SDS at 68‡C with gentle agitation, the membrane
was incubated with 1% nonfat dry milk in maleic
acid bu¡er (1U1032 M maleic acid, 1.5U1032 M
NaCl pH 7.5) for 1 h at 20‡C. The membrane was
washed with maleic acid bu¡er followed by incuba-
tion with alkaline phosphatase-conjugated anti-dig-
oxygenin antibody in maleic acid bu¡er (1:5000,
Boehringer Mannheim, Germany) for 1 h at 20‡C.
After washing with maleic acid bu¡er thoroughly,
the hybridized bands were visualized using NBT/
BCIP. The level of expression was normalized by
comparative hybridization using digoxygenin-labeled
L-actin probe.
2.4. Generation of DNA-PKcs targeting plasmid
The DNA fragment for DNA-PKcs was con-
structed from a human spleen cell cDNA library us-
ing polymerase chain reaction (PCR). PCR were per-
formed at 94‡C 90 s, 58‡C 90 s, 72‡C 90 s for
30 cycles. Primers for PCR were forward 5P-4321
AACAGCACAGAGCATTGAGG-3P and reverse
5P-4803 TGCATGAGCTCCAATACAGC-3P based
on the human DNA-PK catalytic subunit (DNA-
PKcs) cDNA sequence [26]. The produced fragment
of 483 bp was inserted into pTargeT vector (Prom-
ega, WI), downstream from the cytomegalovirus im-
mediate early promoter, and transfected into JM109
according to manufacturer’s instruction. The trans-
fectant was propagated in LB and the plasmid DNA
was extracted as described previously [27]. A portion
of plasmid DNA (3 Wg) was digested with 6 units
SalI restriction endonuclease for DNA sequencing.
The sequencing reaction was performed by the di-
deoxynucleotide termination method using M13 uni-
versal primer 5P-CGACGTTGTAAAACGACGGC-
CAGT-3P and analyzed by ALF sequencer
(Pharmacia, Sweden) as described previously [28].
The sequence was compared with human DNA-
PKcs sequence [26] and the con¢rmed fragment
was inserted into the pTargeT vector. pvDNA-
PKcs was isolated and identi¢ed as an antisense
DNA-PKcs RNA expressing plasmid. The plasmid
DNA (100 Wg) was linearized by digesting with 100
units SalI restriction endonuclease, then precipitated
with 70% ethanol at 320‡C for 8 h. Linearized plas-
mid DNA was collected by centrifugation 10 000Ug
at 4‡C, dissolved in sterile water at a concentration
of 10 Wg/Wl.
2.5. Electroporation
Exponentially growing ML-1 cells (1U107) were
harvested, washed with ice-cold PBS, then resus-
pended in 0.5 ml of RPMI on ice. Cell suspensions
were transferred to electroporation cuvettes (Bio-
Rad) chilled on ice. Linearized plasmid DNA
(50 Wg) was added to the cell suspension. The mix-
ture was incubated on ice for 5 min. Electroporation
was performed at 250 V with a 1000 WF capacitor.
After electroporation, the cuvette was placed on ice
for 10 min. Transfected cells were diluted into 6 ml
RPMI with 10% FCS containing 400 Wg/ml G418
and cultured at 37‡C in a humidi¢ed 5% CO2 incu-
bator. Culture medium was changed every 2 days,
and a transfectant was obtained after a 2 week cul-
ture.
3. Results and discussion
3.1. IR-induced p21 protein expression in ML-1 cells
is inhibited by either Wortmannin or LY294002
In order to begin analysis of the early cellular re-
sponse to DNA damage, we examined the protein
expression levels of p53 and p21 in ML-1 cells to
determine the time of the initial increase of p21 after
induction with 15 Gy IR. The expression of both p53
and p21 began to increase after 2 h. The expression
of p53 reached a plateau at 3 h, while p21 expression
reached maximum level at 4 h (Fig. 1A). At 4 h, a
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Fig. 1. Wortmannin or LY294002 pretreatment diminished Q-irradiation-induced p21 expression at the protein level in ML-1 cells. (A)
Time course of p53 and p21 expression in ML-1 in response to Q-irradiation were examined. Exponentially growing ML-1 cells were
irradiated with 15 Gy. Cell lysates were extracted after incubation for 1^6 h as indicated. Cell lysates (30 Wg) were electrophoresed on
10^20% SDS-PAGE and blotted onto PVDF membrane. The membrane was probed with anti-p53 monoclonal antibody (DO-1) or
with anti-p21 polyclonal antibody (H164) as described in Section 2. (B) Exponentially growing ML-1 cells were treated with 1U1038^
1U1036 M Wortmannin or 1U1037^1U1035 M LY294002 for 30 min, irradiated with 15 Gy or unirradiated, then incubated for 2 h.
Cell lysates (30 Wg) were electrophoresed on 10^20% SDS-PAGE and blotted onto PVDF membrane. The membrane was probed with
either anti-p21 polyclonal antibody (H-164) or anti-p53 monoclonal antibody (DO-1). In addition, the membrane was probed with
anti-L-tubulin monoclonal antibody (5H1) as an internal control. UT is an untreated control lysate and DMSO is a lysate obtained
from irradiated cells treated with vehicle solution only. (C) Histogram of p21 and p53 band intensities quanti¢ed by densitometric
scanning. The fold increase in protein expression, a comparison of the expression with that in untreated control cells, is indicated. (D)
Twenty micrograms of total RNA were subjected to electrophoresis on formaldehyde agarose gel, transferred to a Hybond N mem-
brane, and hybridized with digoxigenin-labeled probes for p21 mRNA. The level of expression was normalized by comparison with
L-actin and indicated as a relative intensity. Ethidium bromide staining of total RNA is shown at the bottom of the ¢gure. Experi-
ments were repeated independently at least 3 times. Typical blots are shown in the ¢gures. The relative expressions of both protein
and mRNA were reproducible (within þ 10%).
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portion of the ML-1 cells began apoptosis (data not
shown). Therefore, we chose the time point of 2 h
after IR, which is prior to the start of cell death, for
further analysis of p21 expression.
Previous studies suggest that p21 protein expres-
sion was enhanced only after DNA damage [19]. We
proposed the existence of a protein stabilization
mechanism that is induced by DNA damage. In or-
der to access the involvement of DNA-PK or ATM
in the stabilization mechanism, Q-irradiation-induced
p21 expression was examined in cells pretreated with
either Wortmannin or LY294002, PI 3-kinase inhib-
itors. ML-1 cells were treated with 1U1038^1U1036
M Wortmannin or 1U1037^1U1035 M LY294002
for 30 min followed by 15 Gy IR. Cells were incu-
bated for 2 h more, then p21 protein expression was
examined (Fig. 1B). IR resulted in a 2.9-fold increase
in p21 expression (Fig. 1C). Pretreatment with either
Wortmannin or LY294002 reduced the IR-induced
p21 expression dose-dependently, with levels reduced
to that of untreated controls at either 1U1036 M
Wortmannin or 1U1036 M LY294002 (Fig. 1B,C).
Incubation of the cells in DMSO, the vehicle solution
for Wortmannin or LY294002, had no e¡ect on in-
creased p21 expression after IR (Fig. 1B,C). The
treatment of the ML-1 cells with either Wortmannin
or LY294002 in the absence of IR did not a¡ect p21
expression (Fig. 1B). These results suggest that the
inhibition of IR-induced p21 expression was the re-
sult of the activity of both Wortmannin and
LY294002.
p53, an upstream p21 transcription factor, is sta-
bilized by phosphorylation through the activity of
ATM or DNA-PK when ML-1 cells are exposed to
C
Fig. 2. Wortmannin or LY294002 pretreatment diminished the
Q-irradiation-induced p21 expression at the protein level in
NIH3T3 cells. (A) The p21 levels increased in response to Q-ir-
radiation in NIH3T3. Exponentially growing NIH3T3 cells
were irradiated at a dose of 15 Gy. Cell lysates were prepared
at the indicated times after irradiation and examined by West-
ern blotting with the anti-p21 polyclonal antibody (C-19). (B)
Exponentially growing NIH3T3 cells were treated with
1U1038^1U1036 M Wortmannin or 1U1037^1U1035 M
LY294002 for 30 min, irradiated with 15 Gy or unirradiated,
then incubated for 2 h. Cell lysates (30 Wg) were electrophores-
ed on 10^20% SDS-PAGE and blotted onto PVDF membrane.
The membrane was probed with anti-p21 polyclonal antibody
(C-19), or with anti-L-tubulin monoclonal antibody (5H1) as an
internal control. (C) The intensities of p21 bands after IR were
quanti¢ed by densitometric scanning. The fold increase in pro-
tein expression, a comparison of the expression with that in un-
treated control cells, is indicated. Experiments were repeated in-
dependently at least 3 times. Typical blots are shown in the
¢gures. The relative expressions of both protein and mRNA
were reproducible (within þ 10%).
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a DNA damaging agent. Wortmannin or LY294002
inhibits the phosphorylation of p53 resulting in its
destabilization. The induction of p53 in ML-1 cells
by exposure to 15 Gy IR was decreased by Wort-
mannin or LY294002 pretreatment (Fig. 1B). p53
induction was reduced 30% by either 1U1036 M of
Wortmannin or 1U1036 M LY294002 (Fig. 1C). The
reduction of induced p53 was less than that of p21.
Treatment of ML-1 cells with either Wortmannin or
LY294002 in the absence of IR did not a¡ect p53
expression (Fig. 1B). To con¢rm that the inhibition
of p21 expression was not due to the inhibition of
transcription through the diminution of p53, we an-
alyzed the levels of p21 mRNA expression at the
time point when Wortmannin or LY294002 pretreat-
ment inhibits the IR-induced p21 protein expression.
Results indicate that p21 mRNA was induced by IR
in cells pretreated with either 1U1038^1U1036 M
Wortmannin or 1U1037^1U1035 M LY294002.
The levels of p21 mRNA induction were identical
to that induced in cells pretreated with DMSO alone
(Fig. 1D). Taken together, these results suggest that
either Wortmannin or LY294002 speci¢cally de-
creased the p21 protein expression while p21
mRNA expression remained una¡ected in these ex-
perimental conditions.
Fig. 3. Q-Irradiation-induced p21 was diminished by Wortmannin or LY294002 pretreatment in SC3VA4. (A) Expression of DNA-
PKcs in SC3VA4 cells was examined by Western blotting. Cell lysates (30 Wg) were electrophoresed on 4^15% SDS-PAGE and blotted
onto PVDF membrane, then probed with anti-DNA-PKcs polyclonal antibody (C-19). DNA-PKcs 460 kDa band was observed in cell
lysates of NIH3T3 but not in SC3VA4 lysates. (B) SC3VA4 cells were irradiated at a dose of 15 Gy or 30 Gy. Cell lysates were pre-
pared at the indicated times after irradiation and electrophoresed on 10^20% SDS-PAGE and blotted onto PVDF membrane, then
probed with anti-p53 monoclonal antibody (DO-1) or with anti-p21 polyclonal antibody (C-19). (C) Exponentially growing SC3VA4
cells were treated with 1U1038^1U1036 M Wortmannin or 1U1037^1U1035 M LY294002 for 30 min, irradiated with 15 Gy or uni-
rradiated, then incubated for 2 h. Cell lysates (30 Wg) were electrophoresed on 10^20% SDS-PAGE and blotted onto a PVDF mem-
brane. The blot was probed with anti-p21 polyclonal antibody (C-19), or with anti-L-tubulin monoclonal antibody (5H1) as an inter-
nal control. (D) The intensities of p21 bands after IR were quanti¢ed by densitometric scanning. The fold increase in protein
expression, a comparison of the expression with that in untreated control cells, is indicated. Experiments were repeated independently
at least 3 times. Typical blots are shown in the ¢gures. The relative expressions of both protein and mRNA were reproducible (within
þ 10%).
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3.2. p21 expression in NIH3T3 cells and in SCID
cells (SC3VA4) is induced by 15 Gy IR and is
inhibited by Wortmannin or LY294002 in a
dose-dependent manner
The Wortmannin/LY294002-sensitive p21 stabili-
zation that is induced by DNA damage may be
mediated by DNA-PK, a PI 3-K family protein. To
examine the role of DNA-PK in the stabilization of
mouse p21 protein expression, we compared the lev-
els of IR-induced p21 in SCID ¢broblast cell line,
whose DNA-PK activity is deleted, with that in
NIH3T3, a mouse ¢broblast with intact DNA-PK
in the presence or absence of either Wortmannin or
LY294002.
First, we tested the time course of p21 protein
expression in NIH3T3 cells after 15 Gy IR. A
marked increase of p21 was observed 2 h after
15 Gy irradiation (Fig. 2A). We chose these condi-
tions for further analysis. As observed in the ML-1
cells, pretreatment of NIH3T3 cells with either Wort-
mannin or LY294002 decreased the IR-induced p21
protein level in a dose-dependent manner. The
2.2-fold p21 induction by IR was reduced to control
level by pretreatment with either 1U1036 M Wort-
mannin or 1U1035 M LY294002 (Fig. 2B,C). Treat-
ment of cells with an equal amount DMSO for dis-
solving inhibitors had no e¡ect on p21 inhibition
(Fig. 2B). The p21 protein level in cells pretreated
with either Wortmannin or LY294002 without IR
was not changed (Fig. 2B).
To determine whether DNA-PK, a possible target
Fig. 4. Construction of DNA-PKcs targeting ML-1 cells. (A) A DNA fragment, encoding nucleotides 4321^4803 of the DNA-PKcs
cDNA, was generated from a human spleen cell cDNA library by PCR and inserted into the pTargeT vector (Promega) at a position
downstream from the cytomegalovirus immediate early promoter and in an antisense direction. The construct was designated
pvDNA-PKcs. (B) Linearized pvDNA-PKcs was transfected into exponentially growing ML-1 and designated ML-1 vDNA-PKcs.
The existence of DNA-PKcs in the transfectant was determined by Western blot analysis. ML-1, ML-1 vDNA-PKcs, and ML-1 trans-
fected with vector alone (ML-1 vector) were irradiated with 15 Gy then incubated for 2 h. Cell lysates were prepared and 30 Wg of
each was electrophoresed on 4^15% SDS-PAGE and blotted onto PVDF membrane, then probed with anti-DNA-PKcs polyclonal
antibody (C-19). DNA-PKcs 350 kDa band was observed in ML-1 and ML-1 vector but not in ML-1 vDNA-PKcs in either un-
treated cells or after irradiation.
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of Wortmannin or LY294002, is involved in p21 sta-
bilization, we examined the IR-induced p21 expres-
sion using the SCID cell line, SC3VA4, whose DNA-
PKcs is deleted (Fig. 3A). After treatment of
SC3VA4 with either 15 Gy or 30 Gy IR, the expres-
sion level of p53, after either 2 or 4 h, was similar to
untreated controls (Fig. 3B). In contrast, the level of
p21 expression increased with both increasing IR
dosage and time after treatment (Fig. 3B).
We investigated whether the inhibitory e¡ect of
Wortmannin or LY294002 on p21 expression in the
NIH3T3 cells would also occur in the SCID cell. The
IR-induced p21 expression in SC3VA4, 4.8-fold of
control, was reduced by pretreatment of cells with
either Wortmannin or LY294002 (Fig. 3C). The re-
duction appeared dependent upon inhibitor dosage
with 1U1036 M Wortmannin reducing expression
to 2.2-fold of control, and 1U1035 M LY294002
pretreatment reducing expression to control levels
(Fig. 3C,D). The p21 protein level in cells pretreated
with Wortmannin or LY294002 followed by a 2 h
incubation without IR was unchanged (Fig. 3C).
Fig. 5. Q-Irradiation-induced p21 was diminished by Wortmannin or LY294002 pretreatment in ML-1 vDNA-PKcs. (A) Exponentially
growing ML-1 vDNA-PKcs cells were treated with 1U1038^1U1036 M Wortmannin or 1U1037^1U1035 M LY294002 for 30 min,
irradiated with 15 Gy followed by a 2 h incubation. Cell lysates (30 Wg) were electrophoresed on 10^20% SDS-PAGE and blotted
onto PVDF membrane, then the blot was probed with either anti-p21 polyclonal antibody (C-19) or anti-p53 monoclonal antibody
(DO-1). The blots were also probed with anti-L-tubulin monoclonal antibody (5H1) as an internal control. (B) Exponentially growing
ML-1 vector cells were irradiated with 15 Gy followed by a 2 h incubation. Cell lysates (30 Wg) were electrophoresed on 10^20%
SDS-PAGE and blotted onto PVDF membrane, then the blot was probed with anti-p21 polyclonal antibody (C-19) or anti-p53 mono-
clonal antibody (DO-1). (C) The intensities of p21 and p53 bands in ML-1 vDNA-PKcs were quanti¢ed by densitometric scanning.
The fold increase in protein expression, a comparison of the expression with that in untreated control cells, is indicated. (D) Total
RNA was extracted from ML-1 vDNA-PKcs cells. Twenty micrograms of total RNA were subjected to electrophoresis on formalde-
hyde agarose gel, transferred to a Hybond N membrane, and hybridized with digoxigenin-labeled probes. The level of expression
was normalized by comparison with L-actin and indicated as a relative intensity. Ethidium bromide staining of total RNA is shown at
the bottom of the ¢gure. Experiments were repeated independently at least 3 times. Typical blots are shown in the ¢gures. The relative
expressions of both protein and mRNA were reproducible (within þ 10%).
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These results suggest that p21 expression induced by
DNA damage is sensitive to Wortmannin or
LY294002 at the protein level, and the target of in-
hibition by those inhibitors is not DNA-PK. There-
fore, DNA-PK is not required for stabilization of the
p21 protein.
3.3. The induction of p21 expression by IR is not
a¡ected by DNA-PKcs targeting in ML-1 cells
In order to con¢rm that the target of inhibition by
Wortmannin or LY294002 is not DNA-PK, we con-
structed a mammalian expression plasmid encoding
antisense DNA-PKcs RNA driven by CMV immedi-
ate early promoter, pvDNA-PKcs (Fig. 4A). After
transfection of ML-1 cells with the plasmid, we ex-
amined the cells for speci¢c antisense targeting of
DNA-PKcs. The e⁄ciency of targeting was deter-
mined by Western blot analysis using anti-DNA-
PKcs antibody. DNA-PKcs expression, a 350 kDa
protein, was not detectable in ML-1 cells transfected
with pvDNA-PKcs, designated ML-1 vDNA-PKcs
(Fig. 4B).
We examined p21 expression in ML-1 vDNA-
PKcs cells 2 h after 15 Gy IR. On Western blots,
the induction of p21 in ML-1 vDNA-PKcs cells ap-
peared similar to that of both ML-1 cells transfected
with vector alone (ML-1 vector) and parental ML-1
cells (Figs. 1 and 5A,B). The expression of p53 was
also similar in parental ML-1, ML-1 vDNA-PKcs
and ML-1 vector cells (Figs. 1 and 5A,B). Next, we
examined the e¡ect of the Wortmannin or LY294002
pretreatment of ML-1 vDNA-PKcs on p21 and p53
expression. By Western blot analysis, the IR-induced
p21 expression, 3.7-fold of control level, was dimin-
ished with increasing dosage of either Wortmannin
or LY294002 pretreatment of ML-1 vDNA-PKcs
(Fig. 5A,C). To determine whether the decrease of
p21 occurred at the protein level, p21 mRNA expres-
sion was examined (Fig. 5D). Wortmannin pretreat-
ment (1U1037 M and 1U1036 M) reduced both p21
mRNA induction by IR to 77% of the p21 expres-
sion by IR-treated cells without inhibitors (Fig. 5D),
and p21 protein expression from 3.7-fold to 2.7-fold
(28% reduction) at 1U1037 M and to 2.3-fold (40%
reduction) at 1U1036 M of control cells (Fig. 5C). In
contrast, LY294002 pretreatment did not a¡ect in-
duction of p21 mRNA (Fig. 5D), but reduced p21
protein expression from 3.7-fold to 2.6-fold (40% re-
duction) at 1U1035 M (Fig. 5A,C). In the parent
ML-1 cells, the p21 protein induction by IR was fully
inhibited by 1U1036 M Wortmannin or 1U1036 M
LY294002 (Fig. 1). Taken together, these results sug-
gest that DNA-PK is not involved in p21 stabiliza-
tion.
3.4. Involvement of the ATM gene product in
p21 stabilization
Failure of IR to activate the G1/S checkpoint in
A-T cells is due to a defective p53 response [29,30].
In addition, it has been demonstrated that this down-
stream pathway, functioning through p21 CDK2, cy-
clin E and the retinoblastoma protein (RB), is defec-
tive in A-T cells [31,32]. We questioned whether the
ATM gene product, another DNA damage-detecting
C
Fig. 6. Q-Irradiation-induced p21 was diminished by Wortmannin or LY294002 pretreatment in AT3ABR or AT1ABR. (A) p53 and
p21 levels increased in response to Q-irradiation in A-T cell lines. Exponentially growing AT3ABR and AT1ABR cells were irradiated
at the indicated dose followed by a 2 h incubation. Cell lysates (30 Wg) were electrophoresed on 10^20% SDS-PAGE and blotted onto
PVDF membrane, then the blot was probed with either anti-p21 polyclonal antibody (C-19) or anti-p53 monoclonal antibody (DO-1).
The blots were also probed with anti-L-tubulin monoclonal antibody (5H1) as an internal control. (B) Exponentially growing
AT3ABR or AT1ABR cells were treated with 1U1038^1U1036 M Wortmannin or 1U1037^1U1035 M LY294002 for 30 min, irradi-
ated with 3 Gy followed by a 2 h incubation. Cell lysates (30 Wg) were electrophoresed on 10^20% SDS-PAGE and blotted onto
PVDF membrane, then the blot was probed with anti-p21 polyclonal antibody (H-164), or with anti-L-tubulin monoclonal antibody
(5H1) as an internal control: top: AT3ABR; bottom: AT1ABR. (C) The intensities of p21 bands were quanti¢ed by densitometric
scanning. The fold increase in protein expression, a comparison of the expression with that in untreated control cells, is indicated. (D)
Total RNA was extracted from AT3ABR or AT1ABR cells. Twenty micrograms of total RNA were subjected to electrophoresis on
formaldehyde agarose gel, transferred to a Hybond N membrane, and hybridized with digoxigenin-labeled probes. The level of ex-
pression was normalized by comparison with L-actin and indicated as a relative intensity. Ethidium bromide staining of total RNA is
shown at the bottom of the ¢gure. Experiments were repeated independently at least 3 times. Typical blots are shown in the ¢gures.
The relative expressions of both protein and mRNA were reproducible (within þ 10%).
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enzyme, is involved in p21 stabilization. For this
purpose, we used two EBV-transformed lymphoblas-
toid cell lines, AT1ABR and AT3ABR, derived from
A-T patients. AT1ABR and AT3ABR have been
shown by others to be devoid of ATM activity [24].
Western blot analysis of p53 and p21 expression in
both cell lines, 2 h after 1^10 Gy IR, revealed an
increase in the level of p53 expression by 1 Gy IR.
Increasing p53 expression plateaued by 3 Gy IR (Fig.
6A). In addition, the level of p21 expression was
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increased by 1 Gy IR and also plateaued 3 Gy IR
(Fig. 6A). In these A-T cells, it is conceivable that
p21 expression was induced, not through transacti-
vation by p53 stabilized by the ATM gene product
activity.
We examined whether the p21 expression is inhib-
ited by pretreatment of cells with Wortmannin or
LY294002. In AT3ABR cells, Wortmannin alone in-
hibited p21 protein expression, while LY294002
alone was less e¡ective (Fig. 6B,C). When AT3ABR
cells were subjected to 3 Gy IR after either Wort-
mannin or LY294002 pretreatment, the IR-induced
p21, 1.6-fold of control, was diminished in a dose-
dependent manner. Wortmannin at 1036 M reduced
p21 expression from 1.6-fold to 1.2-fold, while 1035
M LY294002 reduced p21 expression from 1.6-fold
to 1.1-fold (Fig. 6C). In AT1ABR cells, neither
Wortmannin nor LY294002 pretreatment alone had
any e¡ect on p21 expression (Fig. 6B). However, the
induction of p21 by 3 Gy IR, 2.0-fold of control, was
clearly decreased by either Wortmannin or
LY294002 pretreatment in a dose-dependent manner,
with 1036 M Wortmannin reducing p21 expression
from 2.0-fold to 1.2-fold and 1035 M LY294002 re-
ducing p21 expression from 2.0-fold to 1.4-fold (Fig.
6C). In both cell lines, Wortmannin was more e¡ec-
tive than LY294002 (Fig. 6B,C).
To con¢rm that the reduction of p21 expression in
both AT1ABR and AT3ABR by either Wortmannin
or LY294002 is due to the inhibition of protein sta-
bilization, p21 mRNA expression was examined
under these conditions. Induction of p21 mRNA by
3 Gy IR was observed in both AT1ABR and
AT3ABR cells (Fig. 6D). The p21 mRNA induced
by 3 Gy IR was not diminished by pretreatment with
either Wortmannin or LY294002 in both cells.
In the present study, we used EBV-transformed A-
T lymphoblastoid cells. Thus, p53 in these cells might
form a complex with either EBNA5 or BZLF1 and
could not function [33,34]. Hence, although IR in-
duced p53 levels in both AT1ABR and AT3ABR
cells, it is unclear that the increased p53 functions
properly. Regardless of the status of p53, either
Wortmannin or LY294002 pretreatment diminished
the level of IR-induced p21 protein. Further, p21
mRNA was increased by IR and its level was not
suppressed by either Wortmannin or LY294002 pre-
treatment. These results con¢rm that the expression
of p21 was inhibited at the protein level by these
inhibitors.
3.5. Conclusion
In this report, we demonstrate that the accumula-
tion of p21 protein after irradiation is diminished at
the protein level by pretreatment of cells with either
Wortmannin or LY294002. Our data also indicate
that neither DNA-PK nor the ATM gene product
is the responsive enzyme for stabilization of p21.
Taken together, these results suggest that the in-
crease of p21 protein expression by DNA damage
is accomplished by unidenti¢ed enzymes that are sen-
sitive to either Wortmannin or LY294002. It is note-
worthy that neither Wortmannin nor LY294002 is
speci¢c for the PI 3-kinase family alone. Their inhib-
itory e¡ects are reported for other enzymes including
the UV-stimulated activation of JNK kinase 1 [35],
myosin light chain kinase [36], and bombesin-stimu-
lated phospholipase A2 activity [37]. We cannot tell
whether the DNA damage targets p21 to inhibit ei-
ther the association of E3 ligase or the apparatus for
ubiquitination. Further experiments are planned to
identify the target site on p21 by an in vitro ubiqui-
tination competition assay using a peptide containing
the possible phosphorylation site of p21.
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